Illumina eine noch unentdeckte Nanoperle

(Bloomberg) -- Genetic sequencing giant Illumina Inc. is in talks to acquire cancer-detection startup Grail Inc., according to people familiar with the matter.Illumina could pay more than $8 billion for Grail, said the people, who asked not to be identified as the details aren’t public. The startup h ...

The Federal Trade Commission will seek to stop Illumina Inc's $7.1 billion proposed acquisition of cancer detection test maker Grail Inc, the agency said in a statement on Tuesday.  Shares of Illumina fell 5.2% on Tuesday to $373.88.  The agency said the deal would slow innovation for tests that ...

Illumina completed a takeover of cancer-detection test maker Grail in August 2021, without securing regulatory approval from the European Union.  The European Commission ordered Illumina in December to unwind the deal, three months after it had blocked the merger on concerns the deal would stifle inn ...